GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A - MedPage Today
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
How my sons define freedom as young men with hemophilia - Hemophilia News Today
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Recurrent Strictly Unilateral Extra-Axial Intracranial Hemorrhage in Severe Hemophilia A Without Inhibitors Revealing a Suspected Dural Arteriovenous Fistula: A Case Report - Cureus
Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Investigational Stem Cell Therapy for Hemophilia A - PR Newswire
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe Hemophilia A - Nature
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
New CAAR-T therapy may eliminate hemophilia A treatment blockers: Study - Hemophilia News Today
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
An Initial Diagnosis of Acquired Hemophilia A in an Elderly Male With a Neck Hematoma - Cureus
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients - PR Newswire
Lower-dose gene therapy effective in severe hemophilia A: Study - Hemophilia News Today
A Case Report on Emergency Medicine: Suspected Acquired Hemophilia A in an Older Adult Male - Cureus
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Distribution of people with hemophilia A in the U.S. in 2024, by age group - Statista
Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc - HCPLive
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Ongoing Trial Investigates Switching from Emicizumab to Fitusiran in Hemophilia A, With Guy Young, MD - HCPLive
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Monochorionic diamniotic twin brothers with severe hemophilia A: a case report - Frontiers
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - Frontiers
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Doctors warn eye bleeding can be first sign of hemophilia A - Hemophilia News Today
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
Infection is top killer in acquired hemophilia A, study finds - Hemophilia News Today
Hemophilia B Gene Therapy Continues to Reduce Bleeding - Medscape
Understanding Hemophilia A and B: Essential Insights for Pharmacists - Pharmacy Times
Acquired Hemophilia A With Post‐Phlebotomy Compartment Syndrome - Lam - 2025 - Clinical Case Reports - Wiley Online Library
Newly ID’d F8 mutation could lead to better hemophilia A treatments - Hemophilia News Today
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder - Frontiers
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
Encouraging Phase 3 Data Released: Marstacimab for Hemophilia A or B With Inhibitors - Docwire News
Byron family shares son’s journey with Severe Hemophilia A - MyStateline
ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B - Contemporary Pediatrics
FRONTIER Trials Support BLA for Investigational Hemophilia A Drug - Docwire News
Roctavian Gene Therapy Controls Bleeding for Five Years in Severe Hemophilia A - Managed Healthcare Executive
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - Frontiers
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
Pfizer’s Hympavzi Cuts Bleeding by 93% in Hemophilia A and B Patients with Inhibitors, Phase 3 Trial Finds - Managed Healthcare Executive
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
Early diagnosis reduces treatment burden in hemophilia A children - Hemophilia News Today
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report - Frontiers
Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran - The American Journal of Managed Care
BioMarin resigned to ending journey with hemophilia A gene therapy Roctavian, seeks divestiture amid sales struggle - Fierce Pharma
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
Discovery could improve treatment for people with hemophilia A - Medical Xpress
Novo Nordisk’s Hemophilia Data Offers Rare Bright Spot as Revenue Guidance Darkens - AD HOC NEWS
Acquired Hemophilia A Presenting as a Spontaneous Soft Tissue Hematoma in an Elderly Male - Cureus
Advances in hemophilia treatment | Windyga | Acta Haematologica Polonica - Via Medica Journals
These Weird Symptoms Could Suggest You Have a Serious Blood Condition - Prevention
Denecimig Well-Tolerated in Hemophilia A After Switching from Emicizumab - HCPLive
Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B - The American Journal of Managed Care
Efficacy of extended half-life factor VIII concentrate (Elocta) compared to standard half-life factor VIII products in patients with severe hemophilia A — impact on treatment adherence and patient preferences | Zdziarska | Acta Haematologica Polonica - Via Medica Journals
Half of Severe Hemophilia A Cases Have No Family History, Delaying Diagnosis but Not Raising Inhibitor Risk - Managed Healthcare Executive
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - The American Journal of Managed Care
International recommendations on the diagnosis and treatment of acquired hemophilia A - Haematologica
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A - The New England Journal of Medicine
Acquired hemophilia A in a patient with small lymphocytic lymphoma and SARS-CoV-2 infection - Via Medica Journals
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A - The New England Journal of Medicine
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A - The New England Journal of Medicine
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A - The New England Journal of Medicine
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A - The New England Journal of Medicine
Anti-CD19 CAR-T cell therapy for acquired hemophilia A - Leukemia - Nature
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film - Fierce Pharma
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs - Nature
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A - The New England Journal of Medicine
Emicizumab Prophylaxis in Hemophilia A with Inhibitors - The New England Journal of Medicine
FDA Approves Jivi for Pediatric Patients Aged 7 to 12 Years With Hemophilia A - The American Journal of Managed Care
Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice - Nature
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A - The New England Journal of Medicine
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A - The New England Journal of Medicine
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History - The New England Journal of Medicine
Articles about Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII - Nature
Treatment options for hemophilia A - Medical News Today
Prediction of hemophilia A severity using a small-input machine-learning framework - Nature
Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A - The New England Journal of Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophili aa,   hemoophilia a,   hemophiliaa,   emophilia a,   hemophiilia a,   hemophili a,   hemophilia ,   hemophi;ia a,   hemophiliaa a,   jemophilia a,   hemohilia a,   hemopilia a,   hemophhilia a,   hemophulia a,   hemophilia a,   hemophilua a,   ehmophilia a,   he,ophilia a,   hempphilia a,   hemmophilia a,   hemiphilia a,   hemopihlia a,   hrmophilia a,   hemophliia a,   hemoohilia a,   hemophilis a,   hemophiliaa ,   hemphilia a,   hemo[hilia a,   hemopgilia a,   heemophilia a,   hemophiliia a,   gemophilia a,   hemophikia a,   hempohilia a,   hmophilia a,   hemophilia aa,   hemophilai a,   hwmophilia a,   hemophiila a,   hemophiloa a,   hemopjilia a,   hemopholia a,   hmeophilia a,   henophilia a,   hemophila a,   hhemophilia a,   hemohpilia a,   hemophlia a,   hemophilia s,   hemophillia a,   hemopphilia a,   hemophiia a,   heomphilia a,   heophilia a
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z